Medifast, Inc. (MED)

Market Cap	157.00M
Revenue (ttm)	602.46M
Net Income (ttm)	2.09M
Shares Out	10.66M
EPS (ttm)	0.19
PE Ratio	77.53
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	329,782
Open	14.52
Previous Close	14.33
Day's Range	14.24 - 14.94
52-Week Range	13.57 - 42.68
Beta	1.16
Analysts	Hold
Price Target	16.50 (+12.02%)
Earnings Date	Feb 18, 2025

About MED

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States and the Asia-Pacific. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, sof...

• Industry: Personal Services
• Sector: Consumer Discretionary
• Founded: 1980
• Employees: 634
• Stock Exchange: NYSE
• Ticker Symbol: MED
• Website: https://medifastinc.com

Financial Performance

In 2024, Medifast's revenue was $602.46 million, a decrease of -43.80% compared to the previous year's $1.07 billion. Earnings were $2.09 million, a decrease of -97.90%.

Analyst Forecast

According to one analyst, the rating for MED stock is "Hold" and the 12-month stock price forecast is $16.5.

Price Target

$16.5

(12.02% upside)

Analyst Consensus: Hold